135 Publications (Page 1 of 6)
2020
Impact of Genetic Ancestry on Treatment Toxicity and Racial Disparities in Breast Cancer
Ballinger, Tarah J⋅Ballinger, Tarah J⋅Cunningham, Geneva M⋅Cunningham, Geneva M⋅Wu, Xi⋅Wu, Xi⋅Schneider, Bryan P and Schneider, Bryan P
Current Breast Cancer Reports, 2020-05-12. | Journal Article
 
Precision Prevention: The Current State and Future of Genomically Guided Cancer Prevention
Kassem, Nawal⋅Kassem, Nawal⋅Stout, Leigh Anne⋅Stout, Leigh Anne⋅Hunter, Cynthia⋅Hunter, Cynthia⋅Schneider, Bryan⋅Schneider, Bryan⋅Radovich, Milan and Radovich, Milan
JCO Precision Oncology, (no. 4), pp. 108, 2020-02-00. | Journal Article
 
Relations of Mindfulness and Illness Acceptance With Psychosocial Functioning in Patients With Metastatic Breast Cancer and Caregivers.
Chinh, Kelly⋅Secinti, Ekin⋅Johns, Shelley A⋅Hirsh, Adam T⋅Miller, Kathy D⋅Schneider, Bryan⋅Storniolo, Anna Maria⋅Mina, Lida⋅Newton, Erin V⋅Champion, Victoria L and Mosher, Catherine E
Oncology nursing forum, vol. 47, (no. 6), pp. 739-752, November 1, 2020. | Journal Article
2019
Analytical Validation of Variants to Aid in Genotype-Guided Therapy for Oncology
Swart, Marelize⋅Swart, Marelize⋅Swart, Marelize⋅Swart, Marelize⋅Stansberry, Wesley M⋅Stansberry, Wesley M⋅Stansberry, Wesley M⋅Stansberry, Wesley M⋅Pratt, Victoria M⋅Pratt, Victoria M⋅Pratt, Victoria M⋅Pratt, Victoria M⋅Medeiros, Elizabeth B⋅Medeiros, Elizabeth B⋅Medeiros, Elizabeth B⋅Medeiros, Elizabeth B⋅Kiel, Patrick J⋅Kiel, Patrick J⋅Kiel, Patrick J⋅Kiel, Patrick J⋅Shen, Fei⋅Shen, Fei⋅Shen, Fei⋅Shen, Fei⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Skaar, Todd C⋅Skaar, Todd C⋅Skaar, Todd C and Skaar, Todd C
The Journal of Molecular Diagnostics, vol. 21, (no. 3), pp. 502, May 2019. | Journal Article
 
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis
Saad, Everardo D⋅Squifflet, Pierre⋅Burzykowski, Tomasz⋅Quinaux, Emmanuel⋅Delaloge, Suzette⋅Mavroudis, Dimitris⋅Perez, Edith⋅Piccart-Gebhart, Martine⋅Schneider, Bryan P⋅Slamon, Dennis⋅Wolmark, Norman and Buyse, Marc
The Lancet Oncology, vol. 20, (no. 3), pp. 370, March 2019. | Journal Article
 
Implications of incidental germline findings identified in the context of clinical whole exome sequencing (WES) for guiding cancer therapy
Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Stout, Leigh Anne⋅Stout, Leigh Anne⋅Stout, Leigh Anne⋅Philips, Santosh⋅Philips, Santosh⋅Philips, Santosh⋅Hunter, Cynthia⋅Hunter, Cynthia⋅Hunter, Cynthia⋅Kiel, Patrick⋅Kiel, Patrick⋅Kiel, Patrick⋅Radovich, Milan⋅Radovich, Milan and Radovich, Milan
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. 1581, 2019-05-20. | Journal Article
 
Microsatellite Instability May Predict Response to Sipuleucel-T in Patients With Prostate Cancer
Zhang, Kevin Juan⋅Schneider, Bryan Paul and Albany, Costantine
Clinical Genitourinary Cancer, vol. 17, (no. 3), pp. 239, June 2019. | Journal Article
 
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan and Radovich, Milan
Breast cancer research : BCR, vol. 21, (no. 1), pp. 87, 2019-08-05. | Journal Article
 
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Tolaney, Sara M⋅Guo, Hao⋅Pernas, Sonia⋅Barry, William T⋅Dillon, Deborah A⋅Ritterhouse, Lauren⋅Schneider, Bryan P⋅Shen, Fei⋅Fuhrman, Kit⋅Baltay, Michele⋅Dang, Chau T⋅Yardley, Denise A⋅Moy, Beverly⋅Marcom, P Kelly⋅Albain, Kathy S⋅Rugo, Hope S⋅Ellis, Mathew J⋅Shapira, Iuliana⋅Wolff, Antonio C⋅Carey, Lisa A⋅Overmoyer, Beth⋅Partridge, Ann H⋅Hudis, Clifford A⋅Krop, Ian E⋅Burstein, Harold J and Winer, Eric P
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 37, (no. 22), pp. 1875, 2019-08-01. | Journal Article
2018
Abstract 3882: Functional validation of a genome-wide association study (GWAS) SNP associated with anthracycline-induced congestive heart failure
Wu, Xi⋅Wu, Xi⋅Xue, Gloria⋅Xue, Gloria⋅Gardner, Laura⋅Gardner, Laura⋅Shen, Fei⋅Shen, Fei⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Philips, Santosh⋅Philips, Santosh⋅Cunningham, Geneva⋅Cunningham, Geneva⋅Schneider, Bryan P and Schneider, Bryan P
Cancer Research, vol. 78, (no. 13 Supplement), pp. 3882, 2018-07-01. | Journal Article
 
Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial
Mosher, Catherine⋅Mosher, Catherine⋅Mosher, Catherine⋅Mosher, Catherine⋅Mosher, Catherine⋅Mosher, Catherine⋅Mosher, Catherine⋅Mosher, Catherine⋅Mosher, Catherine⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Secinti, Ekin⋅Li, Ruohong⋅Li, Ruohong⋅Li, Ruohong⋅Li, Ruohong⋅Li, Ruohong⋅Li, Ruohong⋅Li, Ruohong⋅Li, Ruohong⋅Li, Ruohong⋅Hirsh, Adam⋅Hirsh, Adam⋅Hirsh, Adam⋅Hirsh, Adam⋅Hirsh, Adam⋅Hirsh, Adam⋅Hirsh, Adam⋅Hirsh, Adam⋅Hirsh, Adam⋅Bricker, Jonathan⋅Bricker, Jonathan⋅Bricker, Jonathan⋅Bricker, Jonathan⋅Bricker, Jonathan⋅Bricker, Jonathan⋅Bricker, Jonathan⋅Bricker, Jonathan⋅Bricker, Jonathan⋅Miller, Kathy⋅Miller, Kathy⋅Miller, Kathy⋅Miller, Kathy⋅Miller, Kathy⋅Miller, Kathy⋅Miller, Kathy⋅Miller, Kathy⋅Miller, Kathy⋅Schneider, Bryan⋅Schneider, Bryan⋅Schneider, Bryan⋅Schneider, Bryan⋅Schneider, Bryan⋅Schneider, Bryan⋅Schneider, Bryan⋅Schneider, Bryan⋅Schneider, Bryan⋅Storniolo, Anna⋅Storniolo, Anna⋅Storniolo, Anna⋅Storniolo, Anna⋅Storniolo, Anna⋅Storniolo, Anna⋅Storniolo, Anna⋅Storniolo, Anna⋅Storniolo, Anna⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Newton, Erin⋅Newton, Erin⋅Newton, Erin⋅Newton, Erin⋅Newton, Erin⋅Newton, Erin⋅Newton, Erin⋅Newton, Erin⋅Newton, Erin⋅Champion, Victoria⋅Champion, Victoria⋅Champion, Victoria⋅Champion, Victoria⋅Champion, Victoria⋅Champion, Victoria⋅Champion, Victoria⋅Champion, Victoria⋅Champion, Victoria⋅Johns, Shelley⋅Johns, Shelley⋅Johns, Shelley⋅Johns, Shelley⋅Johns, Shelley⋅Johns, Shelley⋅Johns, Shelley⋅Johns, Shelley and Johns, Shelley
Supportive Care in Cancer, vol. 26, (no. 6), pp. 2004, 20180600. | Journal Article
 
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.
Diamond, Jennifer R⋅Diamond, Jennifer R⋅Diamond, Jennifer R⋅Eckhardt, S G⋅Eckhardt, S G⋅Eckhardt, S G⋅Pitts, Todd M⋅Pitts, Todd M⋅Pitts, Todd M⋅van Bokhoven, Adrie⋅van Bokhoven, Adrie⋅Aisner, Dara⋅Aisner, Dara⋅Aisner, Dara⋅Gustafson, Daniel L⋅Gustafson, Daniel L⋅Gustafson, Daniel L⋅Capasso, Anna⋅Capasso, Anna⋅Capasso, Anna⋅Sams, Sharon⋅Sams, Sharon⋅Sams, Sharon⋅Kabos, Peter⋅Kabos, Peter⋅Kabos, Peter⋅Zolman, Kathryn⋅Zolman, Kathryn⋅Zolman, Kathryn⋅Colvin, Tiffany⋅Colvin, Tiffany⋅Colvin, Tiffany⋅Elias, Anthony D⋅Elias, Anthony D⋅Elias, Anthony D⋅Storniolo, Anna M⋅Storniolo, Anna M⋅Storniolo, Anna M⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Gao, Dexiang⋅Gao, Dexiang⋅Gao, Dexiang⋅Tentler, John J⋅Tentler, John J⋅Tentler, John J⋅Borges, Virginia F⋅Borges, Virginia F⋅Miller, Kathy D and Miller, Kathy D
Breast cancer research : BCR, vol. 20, (no. 1), pp. 82, August 2, 2018. | Journal Article
 
Efficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: A Retrospective Review
Kendzierski, Daniel C⋅Schneider, Bryan P and Kiel, Patrick J
Clinical Breast Cancer, vol. 18, (no. 5), pp. e942, October 2018. | Journal Article
 
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.
Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin and Lu, Xiongbin
Nature communications, vol. 9, (no. 1), pp. 4394, October 22, 2018. | Journal Article
 
Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).
Li, Megan⋅Li, Megan⋅Li, Megan⋅Li, Megan⋅Li, M.⋅Mulkey, Flora⋅Mulkey, Flora⋅Mulkey, Flora⋅Mulkey, F.⋅Mulkey, Flora⋅Jiang, Chen⋅Jiang, Chen⋅Jiang, Chen⋅Jiang, C.⋅Jiang, Chen⋅O'Neill, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O’Neil, B.H.⋅O'Neil, Bert H⋅Schneider, B.P.⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Shen, Fei⋅Shen, F.⋅Shen, Fei⋅Shen, Fei⋅Shen, Fei⋅Friedman, Paula N⋅Friedman, Paula N⋅Friedman, Paula N⋅Friedman, P.N.⋅Friedman, Paula N⋅Momozawa, Yukihide⋅Momozawa, Yukihide⋅Momozawa, Yukihide⋅Momozawa, Yukihide⋅Momozawa, Y.⋅Kubo, M.⋅Kubo, Michiaki⋅Kubo, Michiaki⋅Kubo, Michiaki⋅Kubo, Michiaki⋅Niedzwiecki, Donna⋅Niedzwiecki, Donna⋅Niedzwiecki, Donna⋅Niedzwiecki, Donna⋅Niedzwiecki, D.⋅Hochster, Howard S⋅Hochster, Howard S⋅Hochster, H.S.⋅Hochster, Howard S⋅Hochster, Howard S⋅Lenz, Heinz-Josef⋅Lenz, Heinz-Josef⋅Lenz, H.-J.⋅Lenz, Heinz-Josef⋅Lenz, Heinz-Josef⋅Atkins, J.N.⋅Atkins, James N⋅Atkins, James N⋅Atkins, James N⋅Atkins, James N⋅Rugo, Hope S⋅Rugo, H.S.⋅Rugo, Hope S⋅Rugo, Hope S⋅Rugo, Hope S⋅Halabi, Susan⋅Halabi, Susan⋅Halabi, Susan⋅Halabi, Susan⋅Halabi, S.⋅Kelly, W.K.⋅Kelly, William Kevin⋅Kelly, William Kevin⋅Kelly, William Kevin⋅Kelly, William K⋅McLeod, Howard L⋅McLeod, Howard L⋅Mc Leod, Howard L⋅McLeod, Howard L⋅McLeod, H.L.⋅Innocenti, Federico⋅Innocenti, Federico⋅Innocenti, F.⋅Innocenti, Federico⋅Innocenti, Federico⋅Ratain, M.J.⋅Ratain, Mark J⋅Ratain, Mark J⋅Ratain, Mark J⋅Ratain, Mark J⋅Venook, Alan⋅Venook, Alan P⋅Venook, A.P.⋅Venook, Alan P⋅Venook, Alan P⋅Owzar, Kouros⋅Owzar, Kouros⋅Owzar, Kouros⋅Owzar, Kouros⋅Owzar, K.⋅Kroetz, Deanna⋅Kroetz, D.L.⋅Kroetz, Deanna L⋅Kroetz, Deanna L and Kroetz, Deanna L
Clinical cancer research : an official journal of the American Association for Cancer Research, June 5, 2018. | Journal Article
 
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study
Li, Daneng⋅Li, Daneng⋅Li, Daneng⋅Li, Daneng⋅Li, Daneng⋅McCall, Linda⋅McCall, Linda M⋅McCall, Linda M⋅McCall, Linda M⋅McCall, Linda⋅Hahn, Olwen M⋅Hahn, Olwen⋅Hahn, Olwen⋅Hahn, Olwen M⋅Hahn, Olwen M⋅Hudis, Clifford⋅Hudis, Clifford⋅Hudis, Clifford A⋅Hudis, Clifford A⋅Hudis, Clifford A⋅Cohen, Harvey⋅Cohen, Harvey J⋅Cohen, Harvey J⋅Cohen, Harvey⋅Cohen, Harvey J⋅Muss, Hyman⋅Muss, Hyman B⋅Muss, Hyman⋅Muss, Hyman B⋅Muss, Hyman B⋅Jatoi, Aminah⋅Jatoi, Aminah⋅Jatoi, Aminah⋅Jatoi, Aminah⋅Jatoi, Aminah⋅Lafky, Jacqueline⋅Lafky, Jacqueline M⋅Lafky, Jacqueline⋅Lafky, Jacqueline M⋅Lafky, Jacqueline M⋅Ballman, Karla V⋅Ballman, Karla V⋅Ballman, Karla⋅Ballman, Karla V⋅Ballman, Karla⋅Winer, Eric P⋅Winer, Eric⋅Winer, Eric⋅Winer, Eric P⋅Winer, Eric P⋅Tripathy, Debu⋅Tripathy, Debu⋅Tripathy, Debu⋅Tripathy, Debu⋅Tripathy, Debu⋅Schneider, Bryan⋅Schneider, Bryan⋅Schneider, Bryan⋅Schneider, Bryan⋅Schneider, Bryan⋅Barry, William⋅Barry, William⋅Barry, William⋅Barry, William⋅Barry, William⋅Dickler, Maura N⋅Dickler, Maura N⋅Dickler, Maura⋅Dickler, Maura N⋅Dickler, Maura⋅Hurria, Arti⋅Hurria, Arti⋅Hurria, Arti⋅Hurria, Arti and Hurria, Arti
Breast Cancer Research and Treatment, vol. 171, (no. 2), pp. 334, 20180900. | Journal Article
 
Metastatic breast cancer patients’ expectations and priorities for symptom improvement
Tometich, Danielle B⋅Tometich, Danielle B⋅Tometich, Danielle B⋅Tometich, Danielle B⋅Tometich, Danielle⋅Tometich, Danielle B⋅Tometich, Danielle B⋅Tometich, Danielle B⋅Tometich, D.B.⋅Tometich, Danielle B⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Mosher, Catherine⋅Mosher, Catherine E⋅Mosher, Catherine E⋅Mosher, C.E.⋅Hirsh, Adam⋅Hirsh, Adam T⋅Hirsh, A.T.⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Hirsh, Adam T⋅Rand, Kevin L⋅Rand, Kevin L⋅Rand, Kevin L⋅Rand, Kevin⋅Rand, K.L.⋅Rand, Kevin L⋅Rand, Kevin L⋅Rand, Kevin L⋅Rand, Kevin L⋅Rand, Kevin L⋅Johns, Shelley A⋅Johns, Shelley A⋅Johns, Shelley A⋅Johns, Shelley A⋅Johns, Shelley⋅Johns, Shelley A⋅Johns, Shelley A⋅Johns, Shelley A⋅Johns, S.A.⋅Johns, Shelley A⋅Matthias, M.S.⋅Matthias, Marianne S⋅Matthias, Marianne S⋅Matthias, Marianne S⋅Matthias, Marianne S⋅Matthias, Marianne⋅Matthias, Marianne S⋅Matthias, Marianne S⋅Matthias, Marianne S⋅Matthias, Marianne S⋅Outcalt, Samantha D⋅Outcalt, Samantha⋅Outcalt, Samantha D⋅Outcalt, Samantha D⋅Outcalt, S.D.⋅Outcalt, Samantha D⋅Outcalt, Samantha D⋅Outcalt, Samantha D⋅Outcalt, Samantha D⋅Outcalt, Samantha D⋅Schneider, B.P.⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan⋅Schneider, Bryan P⋅Mina, Lida⋅Mina, Lida⋅Mina, L.⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Mina, Lida⋅Storniolo, Anna Maria V⋅Storniolo, Anna Maria V⋅Storniolo, Anna Maria V⋅Storniolo, A.M.V.⋅Storniolo, Anna Maria V⋅Storniolo, Anna Maria V⋅Storniolo, Anna⋅Storniolo, Anna Maria V⋅Storniolo, Anna Maria V⋅Storniolo, Anna Maria V⋅Newton, E.V.⋅Newton, Erin V⋅Newton, Erin V⋅Newton, Erin V⋅Newton, Erin V⋅Newton, Erin V⋅Newton, Erin V⋅Newton, Erin V⋅Newton, Erin V⋅Newton, Erin⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, K.D.⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy⋅Miller, Kathy D and Miller, Kathy D
Supportive Care in Cancer, pp. 1-8, May 2018. | Journal Article
 
Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
Gadgeel, Shirish M⋅Pennell, Nathan A⋅Fidler, Mary Jo⋅Halmos, Balazs⋅Bonomi, Philip⋅Stevenson, James⋅Schneider, Bryan⋅Sukari, Ammar⋅Ventimiglia, Jaclyn⋅Chen, Wei⋅Galasso, Cathy⋅Wozniak, Antoinette⋅Boerner, Julie and Kalemkerian, Gregory P
Journal of Thoracic Oncology, vol. 13, (no. 9), pp. 1399, September 2018. | Journal Article
 
Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer
Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Van der Jeught, Kevin⋅VanderJeught, Kevin⋅Van der Jeught, Kevin⋅VanderJeught, Kevin⋅Van der Jeught, Kevin⋅VanderJeught, Kevin⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin and Lu, Xiongbin
Journal of Clinical Investigation, vol. 128, (no. 7), pp. 2951-2965, Jul 2018. | Journal Article
 
Sustained Exceptional Response to Poly (ADP-Ribose) Polymerase Inhibition Plus Temozolomide in Metastatic Melanoma With DNA Repair Deficiency
Kiel, Patrick J⋅Kiel, Patrick J⋅Kiel, Patrick J⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Logan, Theodore F⋅Logan, Theodore F and Logan, Theodore F
JCO Precision Oncology, (no. 2), pp. 7, 2018-11-00. | Journal Article
 
Symptom burden and employment status in breast cancer (BC) survivors
Luis, Ines Maria Vaz Duarte⋅Luis, Ines Maria Vaz Duarte⋅O'Neill, Anne M⋅O'Neill, Anne M⋅Sepucha, Karen⋅Sepucha, Karen⋅Miller, Kathy D⋅Miller, Kathy D⋅Dang, Chau T⋅Dang, Chau T⋅Northfelt, Donald W⋅Northfelt, Donald W⋅Winer, Eric P⋅Winer, Eric P⋅Sledge, George W⋅Sledge, George W⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Partridge, Ann and Partridge, Ann
Journal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. 10073, 2018-05-20. | Journal Article
 
Urgent hypertension as a biomarker for bevacizumab in the curative setting
Kassem, Nawal⋅Shen, Fei⋅Jiang, Guanglong⋅Gardner, Laura⋅Philips, Santosh⋅O'Neill, Anne M⋅Miller, Kathy D⋅Suter, Thomas⋅Cameron, David A⋅Sledge, George W and Schneider, Bryan Paul
Journal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. 548, 2018-05-20. | Journal Article
2017
Abstract 2029: Precision therapeutic combinations are synergistic against triple negative breast cancer using compensatory pathways
Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Hancock, Brad⋅Hancock, Brad⋅Hancock, Brad⋅Paul, Robin⋅Paul, Robin⋅Paul, Robin⋅Kiel, Patrick⋅Kiel, Patrick⋅Kiel, Patrick⋅Skaar, Todd⋅Skaar, Todd⋅Skaar, Todd⋅Schneider, Bryan⋅Schneider, Bryan⋅Schneider, Bryan⋅Radovich, Milan⋅Radovich, Milan and Radovich, Milan
Cancer Research, vol. 77, (no. 13 Supplement), pp. 2029, 2017-07-01. | Journal Article
 
Abstract 5401: Assessment of whole genome amplification for whole exome sequencing in detecting genetic mutation
Xue, Crystal⋅Gardner, Laura⋅Jiang, Guanglong⋅Shen, Fei and Schneider, Bryan
Cancer Research, vol. 77, (no. 13 Supplement), pp. 5401, 2017-07-01. | Journal Article
 
Abstract IA09: Impact of genetically determined race on outcomes in E5103
Schneider, Bryan Paul
Cancer Epidemiology Biomarkers & Prevention, vol. 26, (no. 2 Supplement), pp. IA09, 2017-02-00. | Journal Article